Pneumonia is indicated as a complex infection, which affects the lower part of the respiratory tract along with the deposition of cough in the lungs. It may even occur as a consequence of an upper tract infection. Frequently, it occurs in people with weakened immunity, the geriatric population, and children. Biotechnological methods can be used for testing of pneumonia, such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR).
The major driving factors contributing to the growth of the pneumonia market are an increase in awareness regarding early diagnosis, a rise in the popularity of point of care (POC)testing, and surge in government expenditures on healthcare. However, limited detection capability, the accuracy of some of the pneumonia testing products, and regulatory & economic hurdles hamper the market growth. Some of the factors, such as an increase in the adoption of molecular diagnostic testing and untapped markets in developing countries are expected to provide lucrative growth opportunities for the pneumonia testing market.
The pneumonia testing market is segmented on the basis of, and region. Method, technology, type & end user. In terms of method, the market is classified into immunodiagnostics, molecular diagnostics, and point-of-care (POC) testing. By type, it is bifurcated into analyzers and consumables. Based on technology, it is categorized into enzyme-linked immunosorbent assay (ELISA), immunofluorescence, western blot, polymerase chain reaction (PCR), immunohistochemistry (IHC), and others. Depending on the end-user, it is categorized into hospitals, diagnostic laboratories, home care, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the market include Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton, Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, and Quidel.
The major driving factors contributing to the growth of the pneumonia market are an increase in awareness regarding early diagnosis, a rise in the popularity of point of care (POC)testing, and surge in government expenditures on healthcare. However, limited detection capability, the accuracy of some of the pneumonia testing products, and regulatory & economic hurdles hamper the market growth. Some of the factors, such as an increase in the adoption of molecular diagnostic testing and untapped markets in developing countries are expected to provide lucrative growth opportunities for the pneumonia testing market.
The pneumonia testing market is segmented on the basis of, and region. Method, technology, type & end user. In terms of method, the market is classified into immunodiagnostics, molecular diagnostics, and point-of-care (POC) testing. By type, it is bifurcated into analyzers and consumables. Based on technology, it is categorized into enzyme-linked immunosorbent assay (ELISA), immunofluorescence, western blot, polymerase chain reaction (PCR), immunohistochemistry (IHC), and others. Depending on the end-user, it is categorized into hospitals, diagnostic laboratories, home care, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the market include Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton, Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, and Quidel.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pneumonia testing market analysis from 2020 to 2030 to identify the prevailing pneumonia testing market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the pneumonia testing market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global pneumonia testing market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Types
- Consumables
- Analyzers
By Method
- Molecular Diagnostics
- Point of Care Testing
- Immunodiagnostics
By Technology
- Enzyme Linked Immunosorbant Assay
- Immunofluoroscence
- Western Blot
- Polymerase Chain Reaction
- Imunohistochemistry
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Homecare
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Abott Laboratories
- F.hoffman La roche
- Thermofischer Inc
- Hologic Inc
- Biomerieux SA
- Quidel Corporation
- Bio Rad laborateries
- Beckton and Dickinson Company
- AdvanDx
- Beckman Coulter
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: PNEUMONIA TESTING MARKET, BY TYPES
CHAPTER 5: PNEUMONIA TESTING MARKET, BY METHOD
CHAPTER 6: PNEUMONIA TESTING MARKET, BY TECHNOLOGY
CHAPTER 7: PNEUMONIA TESTING MARKET, BY END USER
CHAPTER 8: PNEUMONIA TESTING MARKET, BY REGION
CHAPTER 9: COMPANY LANDSCAPE
CHAPTER 10: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Pneumonia Testing Market,' thePneumonia Testing Market Size was valued at $1.6 billion in 2020, and is estimated to reach $3.0 billion by 2030, growing at a CAGR of 6.5% from 2021 to 2030.Pneumonia is a type of lung infection caused by bacteria, such as the Streptococcus pneumonia virus, fungi, and parasites. In pneumonia, the air sacs of the lungs called alveoli are filled with fluid or pus that causes inflammation. The symptoms of pneumonia include short breathing, fever, chest pain, nausea & vomiting. However, these clinical symptoms overlap with many other diseases, such as asthma, bronchitis, and the common cold, making it difficult to diagnose pneumonia. Physicians recommend tests such as blood tests, sputum tests, pleural fluid cultures, and pulse oximetry tests to confirm the onset of pneumonia.
This disease is most prevalent in South Asia and African countries. The key factors that drive Pneumonia Testing Market Growth include an increase in technological advancement in pneumonia testing systems, such as the development of enhanced nucleic acid detection tests and advancement in point of care (POC) tests.
Moreover, an increase in awareness toward early diagnosis and a rise in government expenditures on healthcare fuel the market growth. However, the limited detection capability & accuracy of some of the pneumonia testing products and regulatory & economic hurdles hamper the market growth. Conversely, the surge in the adoption of molecular diagnostic testing and high untapped market potential in developing countries are anticipated to provide lucrative growth opportunities for the market.
The Pneumonia Testing Industry is segmented on the basis of method, technology, type & end-user region. In terms of method, it is classified into immunodiagnostics, molecular diagnostics, and point-of-care (POC) testing. By type, it is bifurcated into analyzers and consumables. Based on technology, it is categorized into enzyme-linked immunosorbent assay (ELISA), immunofluorescence, western blot, polymerase chain reaction (PCR), immunohistochemistry (IHC), and others. Depending on the end-user, it is classified into hospitals, diagnostic laboratories, home care, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The POC testing segment was the major contributor to the market in 2020, due to multiple benefits offered by this technique, such as technological advancements, ease of use, and rapid results. The analyzers segment is estimated to register the highest growth rate during the forecast period, owing to t their frequent usage for pneumonia tests from 2020-to 2030.
Polymerase chain reaction registered the highest growth rate in the forecast period among the different technologies, as this test can identify the causative agent and accurately detect pneumonia in patients. Among the end-user, the hospital occupied the major share of the pneumonia testing market in 2021, due to a large number of patients suffering from pneumonia across the world.
Region-wise the Pneumonia Testing Market Analysis is done across North America, Europe, Asia-Pacific, and LAMEA, in 2020, North America accounted for the maximum Pneumonia Testing Market Share in 2020, owing to the rise in prevalence of pneumonia and a surge in technological advancements in various pneumonia testing products. However, Asia-Pacific is projected to grow at the highest CAGR during the forecast period, owing to an increase in investments by major companies in R&D activities.
Key findings of the Study
- By the method, the point of care test was the highest contributor to the market in 2020.
- By technology, the enzyme-linked immunosorbent assay (ELISA) was the highest contributor to the Pneumonia Testing Industry in 2020.
- By type, the analyzers were the highest contributor to the market in 2020.
- By end-user, the hospitals were the highest contributor to the market in 2020.
- Region-wise, North America garnered the largest revenue share in 2020; however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Abott Laboratories
- F.hoffman La roche
- Thermofischer Inc
- Hologic Inc
- Biomerieux SA
- Quidel Corporation
- Bio Rad laborateries
- Beckton and Dickinson Company
- AdvanDx
- Beckman Coulter
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
